Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Double Blind Randomized Clinical Trial of Use of Colchicine Added to Standard Treatment in Hospitalized Patients With Covid-19 Infection

NCT04997551 is registered in ClinicalTrials.gov with Biogipuzkoa Health Research Institute as lead sponsor.

NCT NCT04997551
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04997551 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Double Blind Randomized Clinical Trial of Use of Colchicine Added to Standard Treatment in Hospitalized Patients With Covid-19 Infection
Lead sponsor
Biogipuzkoa Health Research Institute
Phase
Phase 3
Overall status
Unknown status
Start date
September 8, 2020
Completion date
January 1, 2022
Enrollment
752 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19 infection